Health and Fitness Health and Fitness
Sat, January 9, 2010
[ Sat, Jan 09th 2010 ] - Market Wire
Prospect Medical Holdings to Present at Jefferies 2010 Global Healthcare Services Conference
Fri, January 8, 2010
[ Fri, Jan 08th 2010 ] - Market Wire
IntegraMed®a?s Vein Clinics Segment to Open aEnh .. eda Vein Clinic in Columbia, Maryland in Mid 2010
[ Fri, Jan 08th 2010 ] - Market Wire
Synta Pharmaceuticals Prices $25 Million Public Offering of Common Stock
[ Fri, Jan 08th 2010 ] - Market Wire
Randomized, Double-Blind, Controlled Human Study .. tose® Complex Improves Cognition and Well-Being*
[ Fri, Jan 08th 2010 ] - Market Wire
XenoPort to Present at the 28th Annual J.P. Morgan Healthcare Conference
[ Fri, Jan 08th 2010 ] - Market Wire
Alnylam and Collaborators Discover Key Mechanism for Delivery of RNAi Therapeutics
[ Fri, Jan 08th 2010 ] - Market Wire
Aetna to Announce Fourth Quarter and Full Year 2009 Results
[ Fri, Jan 08th 2010 ] - Market Wire
Obagi Medical Products Served with Complaint from ZO Skin Health, Inc.
[ Fri, Jan 08th 2010 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of BioForm Medical, Inc.
[ Fri, Jan 08th 2010 ] - Market Wire
Labopharm settles $1 million draw down under standby equity distribution agreement
[ Fri, Jan 08th 2010 ] - Market Wire
Health Net Federal Services Patient Appointing Services Contracts Extended
[ Fri, Jan 08th 2010 ] - Market Wire
IMRIS receives regulatory approval in Korea
[ Fri, Jan 08th 2010 ] - Market Wire
China INSOnline Corp. Receives NASDAQ Notice of Noncompliance
[ Fri, Jan 08th 2010 ] - Market Wire
MDS Appoints Steve West MDS Inc. Chief Executive Officer
[ Fri, Jan 08th 2010 ] - Market Wire
Adeona Announces Additional $860,000 Grant for Oral Estriol Multiple Sclerosis Clinical Trial
[ Fri, Jan 08th 2010 ] - Market Wire
MoneyTV; IDO Security, Inc.; Turbine Truck Engine .. ; Brewer Investment Group; Lucas Energy, Inc.: Mo
[ Fri, Jan 08th 2010 ] - Market Wire
King Center to Present Health and Wellness Forum
Thu, January 7, 2010
[ Thu, Jan 07th 2010 ] - Market Wire
NovaBay Pharmaceuticals to Present at the Annual OneMedPlace Finance Forum
[ Thu, Jan 07th 2010 ] - Market Wire
Theravance to Present at the 28th Annual J.P. Morgan Healthcare Conference
[ Thu, Jan 07th 2010 ] - Market Wire
Molecular Insight Pharmaceuticals Announces Perso .. n to Align Operations With Development Activities
[ Thu, Jan 07th 2010 ] - Market Wire
Coventry Health Care to Release Fourth Quarter 2009 Financial Results
[ Thu, Jan 07th 2010 ] - Market Wire
Amador Gold Corp. Commences Drilling on Loveland Gold/Copper/Nickel Project West of Timmins
[ Thu, Jan 07th 2010 ] - Market Wire
Sierra Geothermal Appoints Independent Chair for the Special Meeting
[ Thu, Jan 07th 2010 ] - Market Wire
New Leaf Brands Appoints New Chief Financial Officer
[ Thu, Jan 07th 2010 ] - Market Wire
San West Inc. Joins Information Portal StockProfile.com
[ Thu, Jan 07th 2010 ] - Market Wire
MDS to Release Fourth Quarter 2009 Financial Results
[ Thu, Jan 07th 2010 ] - Market Wire
Neovasc to Raise up to $2 Million in Non-Brokered Private Placement
[ Thu, Jan 07th 2010 ] - Market Wire
CONMED Corporation to Announce Fourth Quarter 2009 Financial Results on February 4, 2010
Wed, January 6, 2010
[ Wed, Jan 06th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. n Behalf of Shareholders of BioForm Medical, Inc.
[ Wed, Jan 06th 2010 ] - Market Wire
Biodel Inc. to Present at 28th Annual JPMorgan Healthcare Conference on January 14th, 2010

Biodel Inc. to Present at 28th Annual JPMorgan Healthcare Conference on January 14th, 2010


Published on 2010-01-06 21:00:40 - Market Wire
  Print publication without navigation


DANBURY, Conn.--([ BUSINESS WIRE ])--Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the 28th Annual JPMorgan Healthcare Conference on Thursday, January 14, 2010 at 8:30 a.m. Pacific Time.

The JPMorgan Healthcare Conference will be held January 11-14, 2010, at the Westin St. Francis Hotel in San Francisco, California.

Interested parties may access the presentation in the investor relations section of Biodel's website at [ www.biodel.com ] which will link to a live webcast to be archived for 14 days.

About Biodel Inc.

Biodel is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes. Biodel's product candidates are developed using technology which reformulates existing FDA-approved peptide drugs. For further information regarding Biodel, please visit the company's website at [ www.biodel.com ].

BIOD-G

Contributing Sources